medigraphic.com
ISSN 0035-0052 (Print)

2023, Number 4

<< Back Next >>

Rev Mex Pediatr 2023; 90 (4)

Rett syndrome in a male infant with pathogenic variant in MECP2

Cote-Orozco JE, Martínez-Córdoba N, Lince-Rivera I, Córdoba-Gravini JL

Language: Spanish
References: 20
Page: 156-161
PDF size: 276.83 Kb.


ABSTRACT

Introduction: the methyl-CpG binding protein 2 (MECP2) gene is located on chromosome Xq28; Rett syndrome (RS) occurs when there is a mutation in this gene. RS predominantly affects women; however, it can also occur in men. Objective: to describe the clinical characteristics of a male patient with RS. Presentation of case: seven-month-old male patient, who had seizures since birth. At four months he presented neurodevelopmental regression, choreodysonic movements, lack of head growth, dysautonomic symptoms and alterations in respiratory pattern, all of which were suggestive of progressive encephalopathy. Metabolic and infectious etiologies were ruled out. The genetic study revealed pathogenic variant c.806del (p.Gly269Alafs120) in MECP2, confirming the diagnosis of SR. The patient continued to deteriorate until he died. Conclusion: RS in men has a more unfavorable prognosis than women, but the clinical characteristics are similar.


REFERENCES

  1. The Rett Syndrome Diagnostic Criteria Work Group. Diagnostic criteria for Rett syndrome. The Rett syndrome diagnostic criteria work group. Ann Neurol 1988; 23(4): 425-428.

  2. Einspieler C, Marschik PB. Regression in Rett syndrome: developmental pathways to its onset. Neurosci Biobehav Rev 2019; 98: 320-332. doi.org/10.1016/j.neubiorev.2019.01.028

  3. Zoghbi HY. Rett syndrome and the ongoing legacy of close clinical observation. Cell. 2016; 167(2): 293-297. doi.org/10.1016/j.cell.2016.09.039

  4. Wan M, Lee SSJ, Zhang X, Houwink-Manville I, Song HR, Amir RE et al. Rett syndrome and beyond: recurrent spontaneous and familial MECP2 mutations at CpG hotspots. Am J Hum Genet 1999; 65(6): 1520-1529. doi.org/10.1086/302690

  5. Neul JL, Fang P, Barrish J, Lane J, Caeg EB, Smith EO et al. Specific mutations in methyl-CpG-binding protein 2 confer different severity in Rett syndrome. Neurology 2008; 70(16): 1313. Available in: https://doi.org/10.1212/01.WNL.0000291011.54508.AA

  6. Villard L. MECP2 mutations in males. J Med Genet 2007; 44(7): 417-423. doi.org/10.1136/jmg.2007.049452

  7. Inuzuka LM, Guerra-Peixe M, Macedo-Souza LI, Pedreira CC, Gurgel-Gianetti J, Monteiro FP et al. MECP2-related conditions in males: a systematic literature review and 8 additional cases. Eur J Paediatr Neurol 2021; 34: 7-13. doi.org/10.1016/j.ejpn.2021.05.013

  8. Gold WA, Krishnarajy R, Ellaway C, Christodoulou J. Rett syndrome: a genetic update and clinical review focusing on comorbidities. ACS Chem Neurosci 2018; 9(2): 167-176. doi.org/10.1021/acschemneuro.7b00346

  9. Krishnaraj R, Ho G, Christodoulou J. RettBASE: Rett syndrome database update. Hum Mutat 2017; 38(8): 922-931.

  10. Ravn K, Nielsen JB, Uldall P, Hansen FJ. No correlation between phenotype and genotype in boys with a truncating MECP2 mutation. J Med Genet 2003; 40: 5.

  11. Kankirawatana P, Leonard H, Ellaway C, Scurlock J, Mansour A, Makris CM et al. Early progressive encephalopathy in boys and MECP2 mutations. Neurology 2006; 67(1): 164-166. doi.org/10.1212/01.wnl.0000223318.28938.45

  12. Pascual-Alonso A, Martínez-Monseny AF, Xiol C, Armstrong J. MECP2-related disorders in males. Int J Mol Sci 2021; 22(17): 1-16. doi.org/10.3390/ijms22179610

  13. Neubauer BA. Rett syndrome. Neuropediatrics 2018; 49(2): 161-162. doi.org/10.1055/s-0037-1609054

  14. Leuzzi V, Di Sabato ML, Zollino M, Montanaro ML, Seri S. Early-onset encephalopathy and cortical myoclonus in a boy with MECP2 gene mutation. Neurology 2004; 63(10): 1968-1970. doi.org/10.1212/01.WNL.0000144350.97844.94

  15. Neul JL, Benke TA, Marsh ED, Skinner SA, Merritt J, Lieberman DN et al. The array of clinical phenotypes of males with mutations in Methyl-CpG binding protein 2. Am J Med Genet Part B Neuropsychiatr Genet 2019; 180(1): 55-67. doi.org/10.1002/ajmg.b.32707

  16. Katz DM, Dutschmann M, Ramirez JM, Hilaire G. Breathing disorders in Rett syndrome: progressive neurochemical dysfunction in the respiratory network after birth. Respir Physiol Neurobiol 2009; 168(1-2): 101. doi.org/10.1016/J.RESP.2009.04.017

  17. Pini G, Bigoni S, Congiu L, Romanelli AM, Scusa MF, Di Marco P et al. Rett syndrome: a wide clinical and autonomic picture. Orphanet J Rare Dis 2016; 11(1): 132. doi.org/10.1186/s13023-016-0499-7

  18. Naidu S, Kaufmann WE, Abrams MT, Pearlson GD, Lanham DC, Fredericksen KA et al. Neuroimaging studies in Rett syndrome. Brain Dev 2001; 23(SUPPL. 1): 62-71. doi.org/10.1016/S0387-7604(01)00381-3

  19. Jan TY, Wong LC, Yang MT, Huang CFJ, Hsu CJ, Peng SSF et al. Correlation of dystonia severity and iron accumulation in Rett syndrome. Sci Rep 2021; 11(1): 1-9. doi.org/10.1038/s41598-020-80723-1

  20. Arvio M, Haanpaa M, Pohjola P, Lahdetie J. Report of a novel missense mutation in the MECP2 gene in a middle-aged man with intellectual disability syndrome. Clin Case Rep 2021; 9(8): e04602.




2020     |     www.medigraphic.com